LONDON, 21 October 2011 – Panmure Gordon & Co., a leading independent institutional stockbroker and investment bank, is pleased to announce its appointment as Nominated Adviser and broker to Avacta Group plc (AIM: AVCT) with immediate effect.

Avacta Group provides innovative, high value proprietary technologies and services to the life sciences and healthcare sectors through two divisions: Avacta Analytical and Avacta Animal Health.

Avacta Analytical’s technologies are aimed at reducing the risks and expense associated with biological drug development and thereby improving R&D productivity and reducing final cost of drugs to patients. In Animal Health, Avacta’s point-of-care immunoassay system provides veterinarians with rapid blood test results in the clinic.